EXPLORING THE RELATIONSHIP BETWEEN CYSTATIN C LEVELS AND GLYCATED HEMOGLOBIN IN DIABETIC NEPHROPATHY PATIENTS
Keywords:
Key words: Cystatin C, glycated hemoglobin, diabetic nephropathy, glomerular filtration rate, kidney dysfunction.Abstract
Diabetic nephropathy (DN) is a severe complication of diabetes mellitus, characterized by progressive kidney damage due to prolonged hyperglycemia. Early detection and monitoring of kidney function are crucial for managing DN and preventing further renal deterioration. Traditionally, serum creatinine has been used to assess renal function; however, it has limitations, particularly in detecting early stages of kidney dysfunction.
Cystatin C has emerged as a promising biomarker for more accurately assessing glomerular filtration rate (GFR) and overall renal function, as it is less influenced by muscle mass and other factors that affect creatinine levels. Additionally, cystatin C1 has been found to correlate with diabetic complications, making it a relevant marker in DN.
This study aimed to explore the relationship between cystatin C levels and glycated hemoglobin (HbA1c) in diabetic nephropathy patients, with a focus on patients categorized based on their GFR, calculated using a combined creatinine-cystatin C formula.
References
1. Shlipak, M.G., Mattes, M.D., & Peralta, C.A. (2013). Update on cystatin C: incorporation into clinical practice. American Journal of Kidney Diseases, 62(3), 595-603.
2. Navarro-González, J.F., Mora-Fernández, C., & Muros de Fuentes, M. (2011). Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology, 7(6), 327-340.
3. Roscioni, S.S., Heerspink, H.J.L., & de Zeeuw, D. (2014). The effect of glycemic control on renal outcomes in patients with type 2 diabetes. Nephrology Dialysis Transplantation, 29(Suppl 4), iv51-iv58.
4. Botirova N. A. DIAGNOSTIC SIGNIFICANCE OF KLOTHO AND CYSTATIN C IN THE EARLY STAGE OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITEUS //Proceedings of International Conference on Scientific Research in Natural and Social Sciences. – 2024. – Т. 3. – №. 2. – С. 111-113.
5. Botirova N. A., Mirahmedova H. T. SIGNIFICANCE OF STANDARD AND NEWLY STUDIED BIOMARKERS IN THE DIAGNOSIS OF ADVANCED CHRONIC KIDNEY DISEASE AGAINST THE BACKGROUND OF DIABETIC NEPHROPATHY IN TYPE 2 DIABETES //Western European Journal of Medicine and Medical Science. – 2023. – Т. 1. – №. 3. – С. 5-10.
6. Мирахмедова Х. Т., Ботирова Н. А. Кандли диабетнинг 2-типида ривожланган сурункали буйрак касаллигини эрта ташхислашда Клото хамда цистатин С нинг ахамияти: дис. – Ташкентская медицинская академия, Ташкент, Узбекистан, 2024.
7. Мирахмедова Х. Т., Ботирова Н. А. 2-тип кандли диабет билан огриган беморларда диабетик нефропатиянинг эрта боскичида клото омилининг ахамияти: дис. – Ташкентская медицинская академия, Ташкент, Узбекистан, 2024.
8. Мирахмедова, Хилола Тухтасиновна, and Ботирова Нигина. "Actual Problems of Diabetic Nephropathy, Risk Factors, Stages, Progression, Mechanism, Diagnosis and Management." (2022).
